White Papers

  1. Patient Diaries Done Right: A Blueprint For Success 11/18/2024

    Discover how patient diaries can improve data quality and engagement, as well as best practices to design, deploy, and monitor diaries that work for both participants and researchers.

  2. Bladder Cancer Global Clinical Trial Landscape (2024) 11/12/2024

    Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.

  3. Practical Strategies For Diverse Trial Recruitment 11/11/2024

    The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.

  4. The Rapid Digitization Of Trials 11/7/2024

    It’s no secret that more trials are going digital. Hear from a panel of industry experts including Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) as they discuss the evolution of digital trials and share their experiences.

  5. The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting 10/30/2024

    The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.

  6. Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments 10/30/2024

    Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.

  7. Agile Use In Non-Software Project 10/28/2024

    Agile methodology, initially for software development, is now valuable for pharmaceutical and medical device projects, enhancing flexibility, stakeholder satisfaction, and adapting to non-software needs.

  8. Compliance Auditing: Diving Into Common Critical Findings 10/28/2024

    Review critical findings in compliance audits, highlighting frequent issues, their impact on operations, and steps companies can take to improve regulatory compliance.

  9. Implementation of the New European Health Technology Assessment Regulation (HTAR) 10/28/2024

    The European Health Technology Assessment Regulation (HTAR) requires joint clinical assessments for certain therapies starting 2025, impacting market access preparation for companies in the EU.

  10. Comparing Patient And Practice Characteristics 10/24/2024

    Explore research that suggests investments to expand the clinical research footprint among practices with low research engagement could help address persistent inequities in cancer clinical trial representation.